Cleo Diagnostics Ltd (ASX:COV)

Cleo Diagnostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
Cash & Equivalents	6.46	9.37	0.24
Cash & Short-Term Investments	6.46	9.37	0.24
Cash Growth	-31.07%	3809.00%	-
Other Receivables	0.07	0.06	0.03
Receivables	0.07	0.06	0.03
Prepaid Expenses	0.01	0.01	0.31
Total Current Assets	6.55	9.44	0.58
Property, Plant & Equipment	0.03	0.03	0.04
Other Intangible Assets	0.36	0.41	0.46
Total Assets	6.94	9.88	1.08
Accounts Payable	0.87	0.27	0.31
Accrued Expenses	0.1	0.05	0
Short-Term Debt	-	-	1.6
Other Current Liabilities	0.13	0.17	0.1
Total Current Liabilities	1.1	0.49	2.02
Total Liabilities	1.1	0.49	2.02
Common Stock	13.71	13.71	0.05
Retained Earnings	-9.53	-5.53	-1.77
Comprehensive Income & Other	1.66	1.22	0.78
Shareholders' Equity	5.83	9.39	-0.94
Total Liabilities & Equity	6.94	9.88	1.08
Total Debt	-	-	1.6
Net Cash (Debt)	6.46	9.37	-1.36
Net Cash Growth	-31.07%	-	-
Net Cash Per Share	0.05	0.08	-0.05
Filing Date Shares Outstanding	128.5	128.5	44.09
Total Common Shares Outstanding	128.5	128.5	44.09
Working Capital	5.44	8.95	-1.44
Book Value Per Share	0.05	0.07	-0.02
Tangible Book Value	5.48	8.98	-1.4
Tangible Book Value Per Share	0.04	0.07	-0.03
Machinery	0.05	0.04	0.04

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.